Reviewing the evolving role of maintenance therapy in multiple myeloma
In this video, Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the evolving role of maintenance therapy in multiple myeloma (MM), highlighting the importance of maintenance in both older and younger patients. Dr Richardson also briefly mentions the expanding treatment options being used in the maintenance setting. This interview took place at the 11th World Congress on Controversies in Multiple Myeloma (COMy) congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Видео Reviewing the evolving role of maintenance therapy in multiple myeloma канала VJHemOnc – Video Journal of Hematology & HemOnc
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Видео Reviewing the evolving role of maintenance therapy in multiple myeloma канала VJHemOnc – Video Journal of Hematology & HemOnc
Speaker: Paul Richardson Institution: Dana-Farber Cancer Institute Event: COMy 2025 Format: Interview Subject: Multiple Myeloma Field: Treatment Field: Immuno-Oncology Field: Perspectives Medicines: Lenalidomide Medicines: Daratumumab Medicines: Isatuximab Medicines: Antibodies Medicines: Melphalan Trial: CEPHEUS Trial: IMROZ maintenance therapy NCT03319667 NCT03652064 MM
Комментарии отсутствуют
Информация о видео
20 мая 2025 г. 19:05:58
00:01:47
Другие видео канала